Tony Hunt
Chief Executive Officer chez REPLIGEN CORPORATION
Fortune : 36 M $ au 29/02/2024
Profil
Actuellement, Tony J. Hunt est président, chef de la direction et directeur de Repligen Corp. M. Hunt a précédemment occupé le poste de directeur principal des programmes pharmaceutiques chez Applied Biosystems, Inc. et de président de la bioproduction chez Life Technologies Corp. Tony J. Hunt a obtenu un diplôme de premier cycle et un diplôme d'études supérieures de la National University of Ireland et un MBA de la Questrom School of Business.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
REPLIGEN CORPORATION
0,33% | 18/03/2024 | 183 249 ( 0,33% ) | 36 M $ | 29/02/2024 |
908 DEVICES INC.
0,03% | 04/03/2024 | 8 886 ( 0,03% ) | 65 312 $ | 29/02/2024 |
Postes actifs de Tony Hunt
Sociétés | Poste | Début |
---|---|---|
REPLIGEN CORPORATION | Chief Executive Officer | 21/05/2015 |
908 DEVICES INC. | Director/Board Member | 02/03/2022 |
Anciens postes connus de Tony Hunt
Sociétés | Poste | Fin |
---|---|---|
Life Technologies Corp.
Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA. | Corporate Officer/Principal | 01/01/2014 |
Applied Biosystems, Inc.
Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Corporate Officer/Principal | 01/01/2008 |
Formation de Tony Hunt
National University of Ireland | Graduate Degree |
Questrom School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
REPLIGEN CORPORATION | Health Technology |
908 DEVICES INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Applied Biosystems, Inc.
Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Health Technology |
Life Technologies Corp.
Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA. | Commercial Services |